• Porträt
• Chart
• News
• Firmenporträt
• ins Musterdepot
• Realtime
• Wertentwicklungsrechner
• 

Suchtext

Start Datum

 01020304050607080910111213141516171819202122232425262728293031 .  010203040506070809101112 .  20232024

Nachrichtenkategorie

AlleTopthemenMarktberichtePolitikUnternehmensberichteDevisenFondsnachrichten

 

Suchergebnis - AMARIN CORP. PLC REG.SHS(SP.ADRS)/1 LS-,50

Zeit	Titel
02.08 13:11	dpa-AFX: GNW-Adhoc: Amarin Reports Second Quarter 2023 Financial Results
31.07 14:00	dpa-AFX: GNW-Adhoc: Amarin and Lotus Pharmaceuticals Announce Exclusive Partnership Agreement to Commercialize Vazkepa® (Icosapent Ethyl) in Southeast Asia and South Korea
26.07 14:00	dpa-AFX: GNW-Adhoc: Latest Research Evaluating Clinical Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the European Society of Cardiology (ESC) Congress
25.07 22:05	dpa-AFX: GNW-Adhoc: Amarin Receives Positive Recommendation from Spanish Drug Pricing Committee for National Reimbursement of VAZKEPA® (icosapent ethyl) in Spain
20.07 14:00	dpa-AFX: GNW-Adhoc: Amarin Board of Directors Announces Executive Compensation Program for New President and CEO Patrick Holt
18.07 22:16	dpa-AFX: GNW-Adhoc: Amarin Appoints Patrick Holt as President and Chief Executive Officer
18.07 22:15	dpa-AFX: GNW-Adhoc: Amarin Implements Organizational Restructuring to Strengthen the Company While Driving Patient Access to VASCEPA®/VAZKEPA® Globally
01.06 12:00	dpa-AFX: GNW-Adhoc: Amarin Partner EddingPharm Receives Regulatory Approval for Vascepa® (Icosapent Ethyl) in Mainland China